Comprehensive Inherited Risk Estimation for Risk-Based Breast Cancer Screening in Women

Nina Mars(Broad Institute), Marco Hautalahti, Robert Graham(GenProMarkers (United States)), Max Tamlander(University of Helsinki), Anne Pitkäranta, Eveliina Jakkula(University of Helsinki), Tuomo J Meretoja(University of Helsinki), Antti Hakanen, Deepak Raipal, Jukka Partanen(Finnish Red Cross), Sirpa Heinävaara(University of Helsinki), George Okafo, Dirk S. Paul(AstraZeneca (United Kingdom)), Simonne Longerich, Anders Mälarstig(Karolinska Institutet), Tarja Laitinen(Tampere University), Tomi P. Mäkelä(University of Helsinki), Sini Kerminen(Institute for Molecular Medicine Finland), Athena Matakidou(AstraZeneca (Sweden)), Markus Perola(Broad Institute), Juhani Junttila(Oulu University Hospital), Jari A. Laukkanen(University of Eastern Finland), Samuli Ripatti(Broad Institute), Bridget Riley-Gills, Matti Pirinen(Broad Institute), Mark I. McCarthy(Centre for Human Genetics), Elisabeth Widén(Institute for Molecular Medicine Finland), Kirsimari Aaltonen(University of Helsinki), Raisa Serpi, Howard J. Jacob(Medical College of Wisconsin), Terhi Kilpi(Finnish Institute for Health and Welfare), Margaret G. Ehm(GlaxoSmithKline (United States)), Adam Platt(AstraZeneca (United Kingdom)), Aarno Palotie(Broad Institute), Heiko Runz(Heidelberg University), Joseph Maranville(Finnish Institute for Health and Welfare), Chris O’Donnell, Eric Green(Janssen (Belgium)), Robert M. Plenge, Mark J. Daly(Broad Institute), Caroline S. Fox(Boston University), Robert Yang, Julie Hunkapiller, Veli‐Matti Kosma(University of Eastern Finland), Sally John, Petri Virolainen, Kirsi Auro(University of Helsinki), Nathan Lawless, K. Klinger(Sanofi (France)), Jaakko Kaprio(University of Helsinki)
Journal of Clinical Oncology
February 29, 2024
Cited by 32


Related Papers